You are here

LUCIGEN CORPORATION

Company Information
Address
2905 PARMENTER ST.
Middleton, WI 53562-0000
United States



Information

UEI: L9SNJEY728V3

# of Employees: 55


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Rapid and Simple Device for Point-of-Care Molecular Detection of Arboviruses

    Amount: $224,997.00

    Expensive equipment highly trained personnel and the need for a clinical laboratory setting precludes routine nucleic acid testing NAT for infectious disease in most of the developing world and ev ...

    SBIRPhase I2016Department of Health and Human Services National Institutes of Health
  2. Tools for Exceptional Overexpression and Structural Stabilization of Membrane Proteins in Mammalian Cells

    Amount: $648,749.00

    DESCRIPTION provided by applicant In this Phase I proposal we plan to develop two technologies to dramatically increase the expression and crystallization of properly folded recombinant membrane p ...

    SBIRPhase I2016Department of Health and Human Services National Institutes of Health
  3. Integrated biochemical and bioinformatic technologies for accurate transcriptome-wide full-length RNA assembly.

    Amount: $697,147.00

    DESCRIPTION provided by applicant The human transcriptome is significantly more complex than its cognate genome due to the hundreds of thousands of possible isoforms allele specific expression i ...

    STTRPhase I2015Department of Health and Human Services National Institutes of Health
  4. Expression Enhanced Natural Product Pathways Using Advanced Metagenomic Tools

    Amount: $698,423.00

    DESCRIPTION provided by applicant A post antibiotic era of multiple drug resistance has begun to threaten the health and well being of mankind A crucial limitation in economically converting untap ...

    SBIRPhase I2015Department of Health and Human Services National Institutes of Health
  5. Mini Chromosome and Fluorescent Proteins for Expression of Protein Complexes

    Amount: $1,499,642.00

    Summary abstract The proteins encoded by the human genome may participate in as many as pairwise protein interactions and nearly every major process in a cell is carried out by assemblies of ...

    SBIRPhase II2015Department of Health and Human Services National Institutes of Health
  6. A Microfluidic System for POC Molecular Diagnosis of HPV in Oral Fluids

    Amount: $225,000.00

    DESCRIPTION provided by applicant The human Papilloma Virus HPV causes a wide variety of diseases in humans including squamous papilloma focal epithelial hyperplasia verruca vulgaris and condyl ...

    SBIRPhase I2015Department of Health and Human Services National Institutes of Health
  7. CLIA-waived Point of Care Test of Infection by Cocci, Blasto, and Histo

    Amount: $150,000.00

    Human cytomegalovirus (CMV) infection causes more cases of congenital disease than 29 currently screened conditions in the US combined & several newborn screening disorders in EU countries. Congenita ...

    SBIRPhase I2014Department of Health and Human Services Centers for Disease Control and Prevention
  8. Antifungal Compound Discovery from Metagenomes

    Amount: $298,997.00

    DESCRIPTION (provided by applicant): There is societal need for new compounds in our arsenal of defenses against fungal pathogens, many of which are increasingly resistant to existing therapeutics. Th ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
  9. BAC Sudoku Sequencing Paradigm to Accelerate Metagenomic Natural Product Chemistr

    Amount: $213,792.00

    DESCRIPTION (provided by applicant): There is societal need for new compounds in our arsenal of defenses against microbial pathogens, many of which are increasingly resistant to existing therapeutics. ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
  10. Novel Cell-based Real Time Platform for GPCR Drug Discovery

    Amount: $300,000.00

    Abstract High throughput screening assays for GPCR drug discovery are hampered by the complex instrumentation associated with current technologies, and the high risk of false-positives and off- target ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government